Enigma Biomedical Group (EBG) and Invicro, a Konica Minolta Company and a provider of imaging services and software for research and drug development, have collaborated on multiple projects, initially focusing on the enhancement of Invicro’s Amyloid and Tau platforms. EBG will be responsible for providing data from their affiliate companies; Cerveau Technologies, Inc. and Meilleur Technologies, Inc.; novel Tau…